Identification of therapeutic target genes with dna microarray in multiple myeloma cell line treated by ikkβ/nf-κb inhibitor

Acta Cirurgica Brasileira

Volumn 29, Issue 11, 2014, Pages 696-702

  Dou, Aixia ^a   Wang, Zhilun ^a   Zhao, Jingjie ^a   Liu, Junli ^a   Zheng, Chengyun ^a  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

Multiple Myeloma; NF kappa B; Protein Interaction Maps

Indexed keywords

BETA7 INTEGRIN; CADHERIN; CD45 ANTIGEN; CD74 ANTIGEN; HLA DR ANTIGEN; I KAPPA B; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN A; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 10; INTERLEUKIN 4; RNA POLYMERASE II; SYNDECAN 4; I KAPPA B KINASE;

ARTICLE; CELL COMMUNICATION; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MULTIPLE MYELOMA CELL LINE; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; ANTAGONISTS AND INHIBITORS; CELL ADHESION; CLUSTER ANALYSIS; GENE TARGETING; GENETICS; METABOLISM; PROCEDURES; REPRODUCIBILITY; TIME; TUMOR CELL LINE;

CELL ADHESION; CELL LINE, TUMOR; CLUSTER ANALYSIS; GENE TARGETING; HUMANS; I-KAPPA B KINASE; MULTIPLE MYELOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84920938156     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502014001800001     Document Type: Article

References (39)

1. Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC. Multiple myeloma. Lancet. 2009 Jul 25;374(9686):324-39. doi:10.1016/S0140-6736(09)60221-X.
2. Pingali SR, Haddad RY, Saad A. Current concepts of clinical management of multiple myeloma. Dis Mon. 2012 Apr;58(4):195-207. doi: 10.1016/j.disamonth.2012.01.006.
3. Dunn JD, Huff CA, Mullins CD, Bugos KG. Oncology pharmacy management and the evolving role of managed care: recommendations for a changing environment with a focus on multiple myeloma. J Manag Care Pharm. 2012 Oct;18(8-a):S3-29.
4. Tao Z-F, Fu W-J, Yuan Z-G, Wang D-X, Chen Y-B, Hou J. Prognostic factors and staging systems of multiple myeloma: a single centre study in China. Chin Med J (Engl). 2007 Oct;120(19): 1655.PMID: 17935664.
5. Bardeleben C, Sharma S, Reeve JR, Bassilian S, Frost PJ, Hoang B, Shi Y, Lichtenstein A. Metabolomics identifies pyrimidine starvation as the mechanism of 5-aminoimidazole-4-carboxamide- 1-β-riboside (AICAr) induced apoptosis in multiple myeloma cells. Mol Cancer Ther. 2013. Jul;12(7):1310-21. doi: 10.1158/1535-7163.MCT-12-1042.
6. Hideshima T, Anderson KC. Molecular mechanisms of novel therapeutic approaches for multiple myeloma. Nat Rev Cancer. 2002 Dec;2(12): 927-37.PMID: 12459731.
7. Alsayed Y, Ngo H, Runnels J, Leleu X, Singha UK, Pitsillides CM, Spencer JA, Kimlinger T, Ghobrial JM, Jia X. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood. 2007 Apr;109(7):2708-17.PMID: 17119115.
8. Brasier AR. The NF-κB regulatory network. Cardiovasc Toxicol. 2006;6(2):111-30.PMID: 17303919.
9. Perkins ND. Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.PMID: 17183360.
10. Gilmore T. The Rel/NF-κB/IκB signal transduction pathway and cancer. Signal Transduction Cancer. 2003 Oct3;13(7):1367-78. doi: 10.1007/0-306-48158-8_10.
11. Cheon JH, Kim JS, Kim JM, Kim N, Jung HC, Song IS. Plant sterol guggulsterone inhibits nuclear factor-κB signaling in intestinal epithelial cells by blocking IκB kinase and ameliorates acute murine colitis. Inflamm Bowel Dis. 2006 Dec;12(12):1152-61.PMID: 17119390.
12. Chauhan D, Uchiyama H, Akbarali Y, Urashima M, Yamamoto K-L, Libermann T, Anderson K. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B. Blood. 1996 Feb;87(3):1104-12.PMID: 8562936.
13. YinJun L, Jie J, YunGui W. Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells. Leuk Res. 2005 Jan;29(1):99-105.PMID: 15541481.
14. Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng W-J, Van Wier S, Tiedemann R, Shi C-X, Sebag M. Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma. Cancer Cell. 2007 Aug;12(2):131-44.PMID: 17692805.
15. Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, Lenz G, Hanamura I, Wright G, Xiao W. Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007 Aug;12(2):115-30.PMID: 17692804.
16. Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, Lenz G, Hanamura I, Wright G, Xiao W, Dave S, Hurt EM, Tan B, Zhao H, Stephens O, Santra M, Williams DR, Dang L, Barlogie B, Shaughnessy JD, Jr., Kuehl WM, Staudt LM. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007 Aug;12(2):115-30. doi: 10.1016/j.ccr.2007.07.004.
17. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, Altman RB. Missing value estimation methods for DNA microarrays. Bioinformatics. 2001 Jun;17(6):520-5.PMID: 11395428.
18. Fujita A, Sato J, Rodrigues LO, Ferreira CE, Sogayar MC. Evaluating different methods of microarray data normalization. BMC Bioinformatics. 2006 Oct;7:469.PMID: 17059609.
19. Smyth GK. Limma: linear models for microarray data, bioinformatics and computational biology solutions using R and Bioconductor. Springer: 2005. p. 397-420. 10.1007/0-387-29362-0_23.
20. Tatusov RL, Natale DA, Garkavtsev IV, Tatusova TA, Shankavaram UT, Rao BS, Kiryutin B, Galperin MY, Fedorova ND, Koonin EV. The COG database: new developments in phylogenetic classification of proteins from complete genomes. Nucleic Acids Res. 2001 Jan;29(1):22-8.PMID: 11125040.
21. Altschu PSF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990 Oct;215(3):403-10.PMID: 2231712.
22. Hosack DA, Dennis Jr G, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003 Sep;4(10):R70.PMID: 14519205.
23. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011 Jan;39(Database issue):D561-8. doi: 10.1093/nar/gkq973.
24. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003 Nov;13(11):2498-504.PMID: 14597658.
25. Gahrton G. Multiple myeloma—a curable disease? J Intern Med. 1992 May;231(5): 449-52.PMID: 1602281.
26. Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi NC, Treon SP, Anderson KC. Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications. Blood. 2002 Jun;99(12):4525-30.PMID: 12036884.
27. Thomas RK, Re D, Wolf J, Diehl V. Part I: Hodgkin’s lymphoma—molecular biology of Hodgkin and Reed-Sternberg cells. Lancet Oncol. 2004 Jan;5(1):11-8.PMID: 14700604.
28. Brown AM, Lally ET, Frankel A, Harwick R, Davis LW, Rominger CJ. The association of the IgA levels of serum and whole saliva with the progression of oral cancer. Cancer. 1975 Apr;35(4):1154-62.PMID: 803867.
29. Plaut AG. The IgA1 proteases of pathogenic bacteria. Annu Rev Microbiol. 1983;37(1):603-22.PMID: 6416146.
30. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity. 1996 Mar;4(3):313-9.PMID: 8624821.
31. Marconi M, Plebani A, Avanzini M, Maccario R, Pistorio A, Duse M, Stringa M, Monafo V. IL-10 and IL-4 co-operate to normalize in vitro IgA production in IgA-deficient (IgAD) patients. Clin Exp Immunol. 1998 Jun;112(3):528-32.PMID: 9649225.
32. Mulligan M, Jones M, Vaporciyan A, Howard M, Ward P. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol. 1993 Nov;151(10):5666-74.PMID: 7901280.
33. Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J. 1990 Aug;4(11):2868-80.PMID: 2199285.
34. Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci. 2003 Jul;94(7):575-81.PMID: 12841864.
35. Teoh G, Anderson KC. Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma. Hematol Oncol Clin North Am. 1997 Feb;11(1):27-42.PMID: 9081202.
36. Neri P, Ren L, Azab AK, Brentnall M, Gratton K, Klimowicz AC, Lin C, Duggan P, Tassone P, Mansoor A. Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion. Blood. 2011 Jun 9;117(23):6202-13. doi: 10.1182/blood-2010-06-292243.
37. de Carvalho F, Colleoni GW, Sampaio Almeida MS, Carvalho AL, Vettore AL. TGFβR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma. Int J Cancer. 2009 Oct 15;125(8):1985-91. doi: 10.1002/ijc.24431.
38. Ekmekci CG, Gutiérrez MI, Siraj AK, Ozbek U, Bhatia K. Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia. Am J Hematol. 2004 Nov;77(3): 33-40.PMID: 15495254.
39. Newman WG, Clayton-Smith J, Metcalfe K, Cole R, Tartaglia M, Brancati F, Morara S, Novelli A, Liu X, Siminovitch KA. Geroderma osteodysplastica maps to a 4 Mb locus on chromosome 1q24. Am J Med Genet A. 2008 Dec 1;146A(23):3034-7. doi: 10.1002/ajmg.a.32564.